“…For variety oriented synthesis, the structure of these bioactive molecules could provide chances for drug design in three important regions (the aromatic ring of the benzopyran, substitution at C2-amine, and the substituted group at C4 position). Therefore, substantial efforts have been made over the past decades for the synthesis of 2 amino-4H-chromenes (Dong et al, 2011, Gao et al, 2008Neelakandan et al, 2011;Ding et al, 2010;Gao et al, 2013), which is accomplished using various catalysts including diethylamine (Kulakarni et al, 2012), ethylenediamine diacetate (Kolla et al, 2012), I 2 (Rajaskhar et al, 2012), PEG (Das et al, 2011), β-cyclodextrin (Murthy et al, 2010), InCl 3 (Jayashree et al, 2009, Shanthi et al, 2008, Yin et al, 2013, guanidine (Kalla et al, 2013), ammonium acetate (Fujimoto et al, 1977), Al 2 O 3 (Roudier and Foucaud 1984), Zr (KPO 4 ) 2 (Massimo et al, 2005), molecular sieves (Yu et al, 2000), aminosilane-modified Fe 3 O 4 nanoparticles (Safari et al, 2014) and silica-bonded 2-hydroxyethylammonium acetate (HEAA) (Sobhani et al, 2013). However, some of these protocols require complex and expensive catalytic systems, prolonged reaction times and complicated operations.…”